Susquehanna International Group, LLP Decibel Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.83 - $5.03 $63,901 - $113,577	-22,580 Reduced 57.27%	16,846 $51,000
Q4 2021 Feb 14, 2022	BUY	$4.57 - $8.58 $77,690 - $145,860	17,000 Added 75.8%	39,426 $183,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $9.04 $148,011 - $202,731	22,426 New	22,426 $173,000
Q2 2021 Aug 11, 2021	SELL	$6.39 - $11.51 $91,319 - $164,489	-14,291 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.56 - $19.9 $150,912 - $284,390	14,291 New	14,291 $162,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.